Alnylam Pharma And Inceptive Nucleics Announce $2B Collaboration Agreement With Upfront Consideration Of $30M, Including Cash And Purchase Of Inceptive Equity

Loading news article.

Alnylam Pharma And Inceptive Nucleics Announce $2B Collaboration Agreement With Upfront Consideration Of $30M, Including Cash And Purchase Of Inceptive Equity | WAPE

Alnylam Pharma And Inceptive Nucleics Announce $2B Collaboration Agreement With Upfront Consideration Of $30M, Including Cash And Purchase Of Inceptive Equity

Article summary

Related companies

Comments —